Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects ...
Integra LifeSciences Holdings Corp. (IART) Securities Fraud Class Action: The litigation focuses on Integra's disclosures related to the FDA's findings of Good Manufacturing Practices violations at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results